Hopefully this article is more positive confirmation of surveillance options for men with low grade and/or low volume biopsy results. I hope I am not duplicating an earlier posting, but this is from the Jan 2015 issue of the Journal of Clinical Oncology. The text is an FAQ about
the study, not too technical at all and very pertinent to those on Active Surveillance or considering it as an option for Gleason 6 low to high volume, or Gleason 7 low volume as I understand the results.
jco.ascopubs.org/content/33/3/238.full